| 000 | 01492 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250513050814.0 | ||
| 264 | 0 | _c19950414 | |
| 008 | 199504s 0 0 eng d | ||
| 022 | _a0022-3565 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aJoseph, D B | |
| 245 | 0 | 0 |
_aThe kappa opioid receptor expressed on the mouse R1.1 thymoma cell line down-regulates without desensitizing during chronic opioid exposure. _h[electronic resource] |
| 260 |
_bThe Journal of pharmacology and experimental therapeutics _cMar 1995 |
||
| 300 |
_a970-6 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _a3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer |
| 650 | 0 | 4 | _aAdenylate Cyclase Toxin |
| 650 | 0 | 4 |
_aAdenylyl Cyclases _xmetabolism |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aBenzeneacetamides |
| 650 | 0 | 4 |
_aCell Membrane _xmetabolism |
| 650 | 0 | 4 | _aDown-Regulation |
| 650 | 0 | 4 | _aIn Vitro Techniques |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 |
_aNaloxone _xmetabolism |
| 650 | 0 | 4 |
_aNaltrexone _xanalogs & derivatives |
| 650 | 0 | 4 | _aPertussis Toxin |
| 650 | 0 | 4 |
_aPyrrolidines _xadministration & dosage |
| 650 | 0 | 4 |
_aReceptors, Opioid, kappa _xagonists |
| 650 | 0 | 4 | _aThymoma |
| 650 | 0 | 4 | _aTumor Cells, Cultured |
| 650 | 0 | 4 |
_aVirulence Factors, Bordetella _xpharmacology |
| 700 | 1 | _aBidlack, J M | |
| 773 | 0 |
_tThe Journal of pharmacology and experimental therapeutics _gvol. 272 _gno. 3 _gp. 970-6 |
|
| 999 |
_c7890685 _d7890685 |
||